RVNC

Revance Therapeutics Inc

Price:

5.66

USD

Volume:

1,561,273.00

United States | Pharmaceuticals

-516.74 %

Upside

As of 2024-02-29, the Fair Value of Revance Therapeutics Inc (RVNC) is -23.59 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.66 USD, the upside of Revance Therapeutics Inc is -516.74%.

Note: valuation result may not be accurate due to the company's negative EPS.

5.66 USD

Stock Price

-23.59 USD

Fair Price

Peter Lynch's formula is:

RVNC Fair Value

= Earnings Growth Rate x TTM EPS
RVNC Fair Value

= 5.00 x -4.72
RVNC Fair Value

= -23.59
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |

Net income | -142.60 | -159.40 | -282.10 | -281.30 | -356.40 | -244.36 |

YoY growth | -18.24% | -11.78% | -76.98% | 0.28% | -26.70% | -26.68% |

Market Cap (mil) | 497.00 |

P/E | |

Forward P/E |

EPS | -4.72 |

Avg earnings growth rate | -26.68% |

TTM earnings | -414.24 |